COUNTERPOINT: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer
In a Significant Percentage of Patients, Neoadjuvant Therapy Yields Equivalent Survival, With Better Quality of Life and Lower Costs
Source: CancerNetwork - Category: Cancer & Oncology Authors: Anna Fagotti, MD, PhD Giovanni Scambia, MD Tags: Gynecologic Cancers Oncology Journal Ovarian Cancer Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Ovarian Cancer | Ovaries